Catalyst Wire Dossier Catalyst Wire Dossier

Autologous bone marrow-derived endothelial cells (BM-ECs) for transplantation

bone marrow-derived endothelial cells · South China Research Center for Stem Cell and Regenerative Medicine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous bone marrow-derived endothelial cells (BM-ECs) for transplantation, covering 2016-12-15 to 2016-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Ischemia [Phase 1]

See pricing